Pain Clinical Trial
— TACE-HAICOfficial title:
Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma: a Prospective Study TACE-HAIC (Transcatheter Arterial Chemoembolization Combined With Hepatic Artery Infusion Chemotherapy )
Previous studies have confirmed that limb pain caused by oxaliplatin chemotherapy is related to spinal cord central sensitization - induced hyperalgesia through oxaliplatin activating spinal cord NMDA receptor(N-methyl-D-aspartic acid receptor). The investigators speculate that this may be the same as the mechanism of severe abdominal pain caused by HAIC(Hepatic Artery Infusion Chemotherapy) during oxaliplatin infusion. The analgesic effect of Esketamine is mainly related to its inhibition of NMDA receptor in spinal cord. Therefore, this study hypothesized that Esketamine can inhibit the sensitization of spinal cord center by inhibiting NMDA receptor, so as to alleviate severe abdominal pain during HAIC perfusion, and reduce abdominal pain caused by ischemia and inflammation by TACE(transcatheter arterial chemoembolization) by improving organ perfusion and anti-inflammatory effect, Therefore, it is expected that Esketamine can better alleviate acute severe abdominal pain caused by TACE-HAIC (transcatheter arterial chemoembolization combined with Hepatic Artery Infusion Chemotherapy )treatment than sufentanil, decrease the dosage of opioids, and reduce the incidence and degree of chronic abdominal pain after treatment.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | April 30, 2023 |
Est. primary completion date | April 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Participate in this study and sign informed consent - Voluntarily receive postoperative intravenous controlled analgesia - Patients receiving TACE-HAIC treatment - HCC (hepatocellular carcinoma)patients with primary liver cancer BCLC(Barcelona Clinic Liver Cancer) stage B and C, liver function A - Age 18 to 80 Exclusion Criteria: - Patients who were unable to cooperate or refused to participate in the trial - Pregnant women - Patients with sensory abnormalities such as diabetes neuropathy - Patients with or having a history of serious mental disorders - Patients with poorly controlled or untreated hypertension (arterial hypertension, resting systolic / diastolic blood pressure more than 180/100mg) - Patients with unstable angina pectoris or myocardial infarction within 6 months or congestive heart failure - Patients with intracranial hypertension or glaucoma - Patients with hyperthyroidism without treatment or insufficient treatment - Patients with severe respiratory dysfunction - Allergy or existing contraindication to chemotherapeutic drugs, opioids or ketamine drugs - Can not follow with the study procedure |
Country | Name | City | State |
---|---|---|---|
China | The Second Affiliated Hospital, Chongqing Medical University | Chongqing | Chongqing |
Lead Sponsor | Collaborator |
---|---|
The Second Affiliated Hospital of Chongqing Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Ramsay Sedation score at 1 hour after HAIC treatment | Ramsay Sedation score is assessed by:
Grade 1 (soberness- the patient is anxious, uneasy or irritable)? Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)? Grade 3 (soberness- the patient only responds to commands)? Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)? Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation. |
From the beginning of HAIC treatment to 1 hour after HAIC treatment | |
Other | Ramsay Sedation score at 2 hours after HAIC treatment | Ramsay Sedation score is assessed by:
Grade 1 (soberness- the patient is anxious, uneasy or irritable)? Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)? Grade 3 (soberness- the patient only responds to commands)? Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)? Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation. |
From 1 hour to 2 hours after HAIC treatment | |
Other | Ramsay Sedation score at 3 hours after HAIC treatment | Ramsay Sedation score is assessed by:
Grade 1 (soberness- the patient is anxious, uneasy or irritable)? Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)? Grade 3 (soberness- the patient only responds to commands)? Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)? Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation. |
From 2 hours to 3 hours after HAIC treatment | |
Other | Ramsay Sedation score at 8 hours after HAIC treatment | Ramsay Sedation score is assessed by:
Grade 1 (soberness- the patient is anxious, uneasy or irritable)? Grade 2 (soberness- the patient is cooperative, has good orientation or is quiet)? Grade 3 (soberness- the patient only responds to commands)? Grade 4 (sleep-the patient responds quickly to light tapping between eyebrows or strong sound stimulation)? Grade 5 (sleep-the patient responds slowly to light tapping between the eyebrows or strong sound stimulation) and Grade 6 (sleep-the patient has no response to light tapping between eyebrows or strong sound stimulation). Grade 1 indicates no sedation ; Grade 2 and 3 indicate good sedation ; Grade 4 to 6 indicate poor sedation. |
From 7 hours to 8 hours after HAIC treatment | |
Other | The quality of sleep on the fist day after HAIC treatment | The Richards-Campbell Sleep Questionnaire (RCSQ) is assessed by the quality of patients' sleep quality.0~25 points indicate poor sleep quality;76~100 points indicate good sleep quality (0-100, 0 represents the worst sleep quality; 100 represents the best sleep quality ;higher scores mean a better outcome) | From the ending of HAIC treatment to 1 day after HAIC treatment | |
Other | The quality of sleep on the second day after HAIC treatment | The Richards-Campbell Sleep Questionnaire (RCSQ) is assessed by the quality of patients' sleep quality.0~25 points indicate poor sleep quality;76~100 points indicate good sleep quality (0-100, 0 represents the worst sleep quality; 100 represents the best sleep quality ;higher scores mean a better outcome) | From 1 day to 2 days after HAIC treatment | |
Other | The quality of sleep on the third day after HAIC treatment | The Richards-Campbell Sleep Questionnaire (RCSQ) is assessed by the quality of patients' sleep quality.0~25 points indicate poor sleep quality;76~100 points indicate good sleep quality (0-100, 0 represents the worst sleep quality; 100 represents the best sleep quality ;higher scores mean a better outcome) | From 2 days to 3 days after HAIC treatment | |
Other | Adverse reaction | Adverse reaction is recorded according to follow-up visits after HAIC treatment | From the beginning of HAIC treatment to 72 hours after HAIC treatment | |
Other | Degree of satisfaction | Degree of satisfaction is assessed by patient using numerical rating scale (0-10, 0 represents unsatisfactory; 10 represents complete satisfaction;higher scores mean a better outcome) | From the beginning of HAIC treatment to 24 hours after HAIC treatment | |
Primary | Maximum pain intensity in the first 3 hours of HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From the beginning of HAIC treatment to 3 hours after HAIC treatment | |
Primary | Pain intensity at 1 hour after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From the beginning of HAIC treatment to 1 hour after HAIC treatment | |
Primary | Pain intensity at 2 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 1 hour to 2 hours after HAIC treatment | |
Primary | Pain intensity at 3 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 2 hours to 3 hours after HAIC treatment | |
Secondary | Numbers of analgesic pump compressions | When the patients felt pain, the patient controlled analgesia pump can be pressed once | From the beginning of HAIC treatment to 48 hours after HAIC treatment | |
Secondary | Analgesic consumption | Analgesic consumption is assessed by the total amount of pain remedy with dolantin when the analgesic effect is poor after pressing analgesic pump for 3 times or more | From the beginning of HAIC treatment to 48 hours after HAIC treatment | |
Secondary | Pain intensity at 8 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 7 hours to 8 hours after HAIC treatment | |
Secondary | Pain intensity at 16 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 15 hours to 16 hours after HAIC treatment | |
Secondary | Pain intensity at 24 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 23 hours to 24 hours after HAIC treatment | |
Secondary | Pain intensity at 32 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 31 hours to 32 hours after HAIC treatment | |
Secondary | Pain intensity at 40 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 39 hours to 40 hours after HAIC treatment | |
Secondary | Pain intensity at 48 hours after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 47 hours to 48 hours after HAIC treatment | |
Secondary | Pain intensity on the seventh days after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 7 days to 8 days after HAIC treatment | |
Secondary | Pain intensity On the 14th day after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 13 days to 14 days after HAIC treatment | |
Secondary | Pain intensity on the 21st after HAIC treatment | Pain intensity is assessed by numerical rating scale pain scores (0-10, 0 represents painless; 10 represents intolerable pain;higher scores mean a worse outcome) | From 20 days to 21 days after HAIC treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|